In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in

Name: In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in
Author: Kommineni, Vally

In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in — المؤلف: Kommineni, Vally — International journal of molecular sciences 20190501

المؤلف: Kommineni, Vally
النشر: International journal of molecular sciences 20190501
الموضوعات: Alkaloids؛ Antibody-Dependent Cell Cytotoxicity؛ Antigens, CD20؛ Fucose؛ Glycosylation؛ Mannose؛ Mannosidases؛ Metabolic Engineering